Crescent Capital BDC, Inc.
CCAP Nasdaq Financials FY2020–FY2025
Last close · Oct 23, 2026
$8.66
1.1%What Crescent Capital BDC, Inc. does
No business description yet.
- Legal name
- Crescent Capital BDC, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 25, 2026
- Accession · CIK
- 0001193125-26-071922
0001633336
Revenue and margins
Crescent Capital BDC, Inc. had $167M of revenue in fiscal 2025, down 15.2% on the year before.
Net income and earnings per share
From fiscal 2020 to 2025, diluted EPS grew 0.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Crescent Capital BDC, Inc. returned $69.1M to shareholders in fiscal 2025. The diluted share count fell 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Crescent Capital BDC, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $10.1M | $6.4M | $7.8M | $10.1M | $5.0M |
| Debt incl. finance leases | $631M | $654M | $845M | $876M | $874M |
| Debt / equity | 1.0x | 1.1x | 1.1x | 1.2x | 1.2x |
| Interest coverage | −2.2x | −1.8x | −1.7x | −1.7x | −1.7x |
| Total assets | $1.3B | $1.3B | $1.6B | $1.7B | $1.6B |
| Total liabilities | $666M | $690M | $885M | $916M | $916M |
| Shareholders' equity | $652M | $613M | $743M | $741M | $706M |
| Net debt (− = net cash) | $621M | $648M | $837M | $866M | $869M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Debt fell relative to assets | — | — | ✕ | ✕ | ✕ | ✕ |
| Current ratio rose | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✓ |
| Gross margin rose | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✓ | ✓ | ✕ |
| F-score | — / 3 | — / 4 | 4 / 7 | 5 / 7 | 3 / 7 | 4 / 7 |
| Accruals ratio | — | 18.3% | −0.9% | −0.6% | 0.9% | −2.5% |
| Altman Z'' | — | — | — | — | — | — |
6 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | — | $94.0M | $117M | $184M | $197M | $167M |
| Operating income | −$26.7M | −$44.1M | −$56.8M | −$100M | −$107M | −$98.7M |
| Interest expense | $15.5M | $19.8M | $31.9M | $58.7M | $62.8M | $57.4M |
| Pretax income | $50.4M | $49.9M | $59.9M | $83.8M | $90.6M | $68.6M |
| Income tax | −$0.1M | $1.7M | −$0.3M | $0.0M | $0.2M | $0.0M |
| Net income | $54.7M | $83.6M | $15.5M | $83.8M | $73.6M | $34.5M |
| Diluted EPS | $1.80 | $1.67 | $1.93 | $2.30 | $2.40 | $1.81 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||
| Cash from operations | −$61.8M | −$158M | $28.0M | $92.3M | $58.9M | $74.7M |
| Share buybacks | $2.2M | — | — | — | — | $1.3M |
| Dividends paid | $42.6M | $47.7M | $55.3M | $64.6M | $75.2M | $67.8M |
| Dividends and buybacks | $44.8M | $47.7M | $55.3M | $64.6M | $75.2M | $69.1M |
| Balance sheet | ||||||
| Cash and short-term investments | $1.7M | $10.1M | $6.4M | $7.8M | $10.1M | $5.0M |
| Total debt | — | $631M | $654M | $845M | $876M | $874M |
| Total assets | — | $1.3B | $1.3B | $1.6B | $1.7B | $1.6B |
| Total liabilities | — | $666M | $690M | $885M | $916M | $916M |
| Shareholders' equity | $560M | $652M | $613M | $743M | $741M | $706M |
| Margins | ||||||
| Operating margin | — | −46.9% | −48.7% | −54.5% | −54.1% | −59.0% |
| Net margin | — | 89.0% | 13.3% | 45.5% | 37.3% | 20.6% |
| Returns | ||||||
| Return on capital | — | −3.3% | −4.5% | −6.3% | −6.6% | −6.3% |
| Return on equity | 9.8% | 13.8% | 2.5% | 12.4% | 9.9% | 4.8% |
| Return on assets | — | 6.3% | 1.2% | 5.7% | 4.5% | 2.1% |
| Return on tangible equity | 9.8% | 12.8% | 2.5% | 11.3% | 9.9% | 4.9% |
| Growth | ||||||
| Revenue growth | — | — | 24.2% | 57.8% | 7.2% | −15.2% |
| Net income growth | — | 53.0% | −81.4% | 439.4% | −12.2% | −53.1% |
| EPS growth | — | −7.2% | 15.6% | 19.2% | 4.3% | −24.6% |
| Share count change | — | 2.9% | 8.5% | 16.3% | 3.2% | −0.0% |
| Financial health | ||||||
| Debt / equity | — | 1.0x | 1.1x | 1.1x | 1.2x | 1.2x |
| Interest coverage | −1.7x | −2.2x | −1.8x | −1.7x | −1.7x | −1.7x |
| Quality scores | ||||||
| Piotroski F-score | — | — | 4.0 | 5.0 | 3.0 | 4.0 |
| Accruals ratio | — | 18.3% | −0.9% | −0.6% | 0.9% | −2.5% |
Source: SEC EDGAR XBRL filings (CIK 0001633336). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
